Breaking News
2 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Centrum relaunches Adults 50+ multivitamin in Canada with cognitive health claims tied to Harvard-affiliated clinical trial data.
Pharma Now Editorial Team
FDA approves Pfizer and Arvinas's vepdegestrant as Veppanu, the third oral SERD cleared for the US breast cancer market.
Pharma Now Editorial Team

Sunshine Lake Pharma wins FDA interchangeable biosimilar status for insulin, entering a US market long held by three multinationals.
Pharma Now Editorial Team

Aurobindo Pharma wins Health Canada approval for a bevacizumab biosimilar, entering the Canadian oncology market against Roche's Avastin.
Pharma Now Editorial Team
